YAJAIRA CERVANTES: Open Payments
NPI 1114660727 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 61 payments from 13 companies in 2025. Trend: 2023 $1,777 · 2024 $1,873 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $442 |
| ABBVIE INC. | 12 | $166 |
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| PFIZER INC. | 5 | $90 |
| Lilly USA, LLC | 4 | $68 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| ALK-Abello, Inc | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Wegovy, UBRELVY, Rybelsus, Ozempic, MOUNJARO, AIRSUPRA, PREVNAR 20, QULIPTA.
Industry payments across TX — which companies pay providers there.
